Lung Cancer | ICHOM – International Consortium for Health Outcomes Measurement
Lung Cancer

Lung Cancer

The ICHOM Standard Set for Lung Cancer is the result of hard work by a group of leading physicians, measurement experts and patients. It is our recommendation of the outcomes that matter most to patients with Lung Cancer. We urge all providers around the world to start measuring these outcomes to better understand how to improve the lives of their patients.

Read the paper on our Lung Cancer Standard Set that was published by European Respiratory Society.


european_urology
Lung Cancer

1 Includes major surgical complications, major radiation complications, and major systemic therapy complications. Recorded via the Common Terminology Criteria for Adverse Events (CTCAE), version 4.0
2 Recorded via the Eastern Cooperative Oncology Group (ECOG) score
3 Recommended to track via the European Organization for Research and Treatment of Cancer Quality of Life Lung Cancer-Specific Questionnaire (EORTC QLQ-LC13)
4 Recommended to track via the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ-C30)
5 Includes physical, emotional, cognitive, and social function and well-being 6 Includes treatment-related mortality and cause of death
6 Includes treatment related mortality and cause of death

© 2015 ICHOM. All rights reserved. When using this set of outcomes, or quoting therefrom, in any way, we solely require that you always make a reference to ICHOM as the source so that this organization can continue its work to define more standard outcome sets.


Team that developed this standard


Australia

Robert Stirling | Monash University

Belgium

Jan van Meerbeeck | Antwerp University Hospital

Brazil

Clarissa Baldatto | Clínicas Oncológicas Integradas

Netherlands

Franz Schramel | St. Antonius Hospital
Suresh Senan | VU University Medical Centre Amsterdam
Michel Wouters | Netherlands Cancer Institute

United Kingdom

Matthew Baker*
David Baldwin | Nottingham University Hospitals
Diana Borthwick | Edinburgh Cancer Research Centre
Jesme Fox | Roy Castle Lung Cancer Foundation
Tom Haswell*
Mick Peake | University Hospital Leicester

United States

Janet Abrahm | Dana-Farber Cancer Institute
David Carbone | Ohio State University Comprehensive Cancer Center
Aileen Chen | Dana-Farber Cancer Institute
Marianna Koczywas | City of Hope National Medical Center
Benjamin Kozower | University of Virginia Health System
Kimberley Mak | Dana-Farber Cancer Institute
Reza Mehran | MD Anderson Cancer Center

*Patient representative

Receive Updates


Reference Guide

A complete overview of the ICHOM Standard Set, including definitions for each measure and selected PROM instruments, time points for collection, and associated risk factors is available here:

dl_ref_guide_lc_3

Version 2.3.1: April 10th, 2017

1,1 MB

Get the Flyer

2,1 MB

Get the Database

40 KB

Get the Article

How to measure?

Interested in measuring the ICHOM Standard Set? Learn how to measure.